Daly Jason B. — SEC Form 4 filings
SEC reporting owner CIK 1906486. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-13.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-05 to 2026-08-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 5 filings — 385,935 shares, $5,252,982 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 39.
- Largest priced transaction: sale of 210,000 shares @ $17.40 ($3,654,000) in Amneal Pharmaceuticals, Inc., filed 2026-08-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Legal Officer | 9 | — | 7 legs · 385,935 sh · $5,252,982 | 39 |
Form 4 filings — Daly Jason B.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-13 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 6,613 @ $17.70 · Sale (S): 210,000 @ $17.40 | EDGAR |
| 2026-03-05 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 22,645 · Tax withholding (F): 10,147 @ $13.31 · Option exercise (M): 38,226 · Tax withholding (F): 16,598 @ $13.31 · Option exercise (M): 24,258 · Tax withholding (F): 10,533 @ $13.31 · +9 more | EDGAR |
| 2026-03-03 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Grant/award (A): 65,359 (derivative) @ $0 · Grant/award (A): 65,359 (derivative) @ $0 | EDGAR |
| 2025-08-13 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 22,000 @ $9.05 | EDGAR |
| 2025-03-07 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 43,064 @ $8.88 · Sale (S): 46,936 @ $8.73 | EDGAR |
| 2025-03-05 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 22,645 · Tax withholding (F): 6,943 @ $8.76 · Option exercise (M): 38,226 · Tax withholding (F): 10,864 @ $8.76 · Option exercise (M): 90,580 · Tax withholding (F): 31,338 @ $8.76 · +8 more | EDGAR |
| 2024-11-22 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 13,665 @ $8.40 | EDGAR |
| 2024-11-19 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 43,657 @ $8.61 | EDGAR |
| 2024-03-05 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 22,645 · Tax withholding (F): 7,166 @ $5.47 · Option exercise (M): 38,226 · Tax withholding (F): 10,864 @ $5.47 · Option exercise (M): 22,645 (derivative) @ $0 · Option exercise (M): 38,226 (derivative) @ $0 · +2 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1906486 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →